Decode News AI
简体繁體

Blood Biomarker Study Finds Clue Toward Diagnosing CTE in Living

2026-11-16 15:07 EST · AI-compiled · 194 words · about 1 min · Views …
Photo: AI-generated illustration

ST. LOUIS - A preliminary study published in JAMA on Nov. 13, 2026, by researchers at Washington University School of Medicine found that a blood protein fragment linked to Alzheimer's disease can also signal advanced chronic traumatic encephalopathy in living patients.

Blood Protein Fragment Tracks Advanced Brain Trauma Pathology

Chronic traumatic encephalopathy, a degenerative brain condition tied to repeated head trauma in athletes and military veterans, can currently only be confirmed through postmortem brain examination. Analyzing samples across 229 participants, researchers found that blood from 11 autopsy-confirmed CTE patients contained elevated levels of the tau fragment eMTBR-tau243 compared with healthy individuals, with levels rising alongside disease severity.

Larger Trials Needed as Early-Stage Detection Remains Elusive

"Many pharmaceutical companies are developing therapies that could potentially treat CTE, but we do not have biomarkers to identify the disease and to rapidly see if a treatment is working," said co-senior author Kanta Horie, a WashU Medicine neurology professor. However, both study authors and outside Northwestern University neuropathologist Dr. Rudolph Castellani cautioned that the test cannot reliably detect early-stage CTE and cannot serve as a standalone tool because Alzheimer's disease raises the same protein.

Sources

Found a factual error or typo? Tell us

Follow Decode News AI on Telegram

Live updates: every new story is pushed the moment it publishes — dozens a day, no digest delay.

@decodenewsai · Subscribe now

Free · unsubscribe anytime

Comments